First Time Loading...

Astellas Pharma Inc
TSE:4503

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
TSE:4503
Watchlist
Price: 1 558 JPY 2.16% Market Closed
Updated: May 3, 2024

Wall Street
Price Targets

Price Targets Summary
Astellas Pharma Inc

Wall Street analysts forecast Astellas Pharma Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Astellas Pharma Inc is 2 070.6 JPY with a low forecast of 1 212 JPY and a high forecast of 3 328.5 JPY.

Lowest
Price Target
1 212 JPY
22% Downside
Average
Price Target
2 070.6 JPY
33% Upside
Highest
Price Target
3 328.5 JPY
114% Upside
Astellas Pharma Inc Competitors:
Price Targets
000640
Dong-A Socio Holdings Co Ltd
34% Upside
GRANULES
Granules India Ltd
7% Upside
AFT
AFT Pharmaceuticals Ltd
26% Upside
OCUL
Ocular Therapeutix Inc
169% Upside
000423
Dong-E-E-Jiao Co Ltd
5% Upside
93M1
MPH Health Care AG
111% Upside
600594
Guizhou Yibai Pharmaceutical Co Ltd
57% Upside
688578
Shanghai Allist Pharmaceuticals Co Ltd
38% Downside

Revenue
Forecast

Revenue Estimate
Astellas Pharma Inc

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's revenue is 2%. The projected CAGR for the next 3 years is 6%.

2%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Astellas Pharma Inc

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's operating income is 1%. The projected CAGR for the next 3 years is 24%.

1%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Astellas Pharma Inc

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's net income is -4%. The projected CAGR for the next 3 years is 28%.

-4%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Astellas Pharma Inc's stock price target?
Price Target
2 070.6 JPY

According to Wall Street analysts, the average 1-year price target for Astellas Pharma Inc is 2 070.6 JPY with a low forecast of 1 212 JPY and a high forecast of 3 328.5 JPY.

What is Astellas Pharma Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's revenue is 2%. The projected CAGR for the next 3 years is 6%.

What is Astellas Pharma Inc's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's operating income is 1%. The projected CAGR for the next 3 years is 24%.

What is Astellas Pharma Inc's Net Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's net income is -4%. The projected CAGR for the next 3 years is 28%.